RECRUITING

Light Therapy for Obsessive-compulsive Disorder (OCD)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to test whether light therapy is effective for reducing symptoms in young adults with OCD and late bedtimes (1am or later). The main question\[s\] it aims to answer are: Does light therapy reduce OCD symptoms? Does light therapy advance the circadian clock? If there is a comparison group: Researchers will compare a higher dose of light therapy to a lower dose to see if dose amount affects symptom reduction. Participants will asked to: 1. Wear light therapy glasses for 1 hour each morning and complete a daily light therapy log for 5 weeks 2. Track their sleep every day with a wearable monitor and an electronic sleep diary for 5 weeks 3. Complete a 1-time assessment of sensitivity to light exposure 4. Complete self-report measures of OCD 4 times/day at baseline (2 weeks), mid-treatment (1 week), and end of treatment (1 week)

Official Title

Light Therapy for Obsessive-compulsive Disorder: a Circadian Medicine Approach

Quick Facts

Study Start:2024-12
Study Completion:2029-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06720090

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 35 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Primary DSM-5 OCD diagnosis
  2. 2. Bedtime 0100 or later
  3. 3. Age 18-35
  4. 4. English speaking
  1. 1. Subjects must not be currently participating in another research study that would influence their participation in our study.
  2. 2. Diagnostic status
  3. 3. Treatment status
  4. 4. Night shift work or travel more than 1 time zone outside of Central Standard Time (CST) in the past month
  5. 5. Pregnancy status
  6. 6. Medication status
  7. 7. Regular nicotine or marijuana use

Contacts and Locations

Study Contact

Rebecca Cox, BA
CONTACT
314-935-8111
scraplab@wustl.edu

Principal Investigator

Rebecca Cox, PhD
PRINCIPAL_INVESTIGATOR
Washington University School of Medicine

Study Locations (Sites)

Washington University
St. Louis, Missouri, 63130
United States

Collaborators and Investigators

Sponsor: Washington University School of Medicine

  • Rebecca Cox, PhD, PRINCIPAL_INVESTIGATOR, Washington University School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12
Study Completion Date2029-03

Study Record Updates

Study Start Date2024-12
Study Completion Date2029-03

Terms related to this study

Keywords Provided by Researchers

  • ocd
  • sleep
  • light therapy
  • circadian
  • behavioral treatment

Additional Relevant MeSH Terms

  • OCD